Pharmaxis Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXS.AX research report →
Price Chart
About the company
Pharmaxis Ltd, an Australian biopharmaceutical company founded in 1998 and based in Frenchs Forest, is globally focused on discovering, developing, and commercializing healthcare solutions for fibrotic and inflammatory conditions. Its operations are organized into two main divisions: the Mannitol Respiratory Business and New Drug Development. Currently, Pharmaxis markets Bronchitol, an inhaled dry powder used in the treatment of cystic fibrosis, and Aridol, a diagnostic tool that identifies hyper-responsive airways to aid in the diagnosis and management of asthma.
- CEO
- Gary Jonathan Phillips BPharm, MBA
- IPO
- 2003
- Employees
- 70
- HQ
- Frenchs Forest, NSW, AU
Get TickerSpark's AI analysis on PXS.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $20.23M
- P/E
- -1.62
- PEG
- -0.02
- P/S
- 3.51
- P/B
- 1.92
- EV/EBITDA
- -1.40
- Div Yield
- 0.00%
- Gross Margin
- 53.06%
- Op Margin
- -205.79%
- Net Margin
- -197.05%
- ROE
- -111.57%
- ROIC
- -65.78%
Latest fiscal year · YoY change
- Revenue
- $5.76M-22.4%
- Gross Profit
- $3.06M+221.1%
- Op Income
- $-11,864,000
- Net Income
- $-11,360,000-486.8%
- EPS
- $-0.02-408.8%
- OCF Growth
- +55.4%
- FCF Growth
- +55.4%
- 52W High
- $0.07
- 52W Low
- $0.03
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- 0.64
- RSI (14)
- 26
- Avg Volume
- 176.42K
No earnings-call transcripts are available for PXS.AX yet.
- Free Float
- 45.6%
- Shares Outstanding
- 722.61M
- Float Shares
- 329.31M
Our PXS.AX coverage
Recent articles, reports, and earnings notes.
No research on PXS.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PXS.AX report →